costco glp-1 program Members Could Gain Access to Drugs Through New Weight-Loss Sam's Club, Costco Selling Cheaper

CagriSema vs Tirzepatide (REDEFINE 4): strong weight loss, but an important endpoint miss Novo Nordisk has announced headline results from the open-label phase 3 REDEFINE 4 trial comparing CagriSema (cagrilintide + semaglutide) vs tirzepatide 15 mg in obesity

It is typically prescribed for individuals who are considered obese, which is generally defined as having a Body Mass Index (BMI) of 30 or higher

Ever since MOTS-c was discovered back in 2015, it has created quite the buzz in the realms of metabolic health, exercise physiology, and longevity science due to its potential to affect the bodys glucose metabolism, stress response, and cellular aging

Finally, clinicians should maintain a low threshold for evaluating patients who report unusual or severe gastrointestinal symptoms, as these may indicate inadvertent overdosing or other complications requiring intervention